Af finity depletion of plasma and serum for mass spectrometry-based proteome analysis

Methods in Molecular Biology

Volumn 1002, Issue , 2013, Pages 1-11

  Jaros, Julian A J ^a   Guest, Paul C ^a   Bahn, Sabine ^a   Martins De Souza, Daniel ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Agilent; Analytical depth; Biomarker; Cerebrospinal fl uid; CSF; Depletion; High abundant; Massspectrometry; Plasma; Removal; Serum; Sigma

Indexed keywords

PROTEOME; PLASMA PROTEIN;

AMINO ACID SEQUENCE; BLOOD SAMPLING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DEPLETION; REVIEW; CHEMISTRY; PLASMA; SERUM; ARTICLE;

BLOOD PROTEINS; HUMANS; MASS SPECTROMETRY; PLASMA; PROTEOME; SERUM;

EID: 84892770807     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-360-2_1     Document Type: Review

References (25)

1. Zhou M, Lucas DA, Chan KC et al (2004) An investigation into the human serum "interactome". Electrophoresis 25:1289-1298
2. Rai AJ, Gelfand CA, Haywood BC et al (2005) HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples. Proteomics 5:3262-3277
3. Burtis CA, Ashwood ER (2001) Tietz fundamentals of clinical chemistry, 5th edn. Saunders Company, Philadelphia, PA
4. Wrotnowski C (1998) The future of plasma proteins. Gen Eng News 18:14
5. Anderson NL, Anderson NG (2002) The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 1:845-867
6. Tirumalai RS, Chan KC, Prieto DA, Issaq HJ, Conrads TP, Veenstra TD (2003) Characterization of the low molecular weight human serum proteome. Mol Cell Proteomics 2:1096-1103
7. Hoffman SA, Joo WA, Echan LA, Speicher DW (2007) Higher dimensional (Hi-D) separation strategies dramatically improve the potential for cancer biomarker detection in serum and plasma. J Chromatogr B Analyt Technol Biomed Life Sci 849:43-52
8. Annesley TM (2003) Ion suppression in mass spectrometry. Clin Chem 49:1041-1044
9. Faca V, Pitteri SJ, Newcomb L et al (2007) Contribution of protein fractionation to depth of analysis of the serum and plasma proteomes. J Proteome Res 6:3558-3565
10. Smith MPW, Wood SL, Zougman A et al (2011) A systematic analysis of the effects of increasing degrees of serum immunodepletion in terms of depth of coverage and other key aspects in top-down and bottom-up proteomic analyses. Proteomics 11:2222-2235
11. Tang H-Y, Beer LA, Barnhart KT, Speicher DW (2011) Rapid veri fi cation of candidate serological biomarkers using gel-based, labelfree multiple reaction monitoring. J Proteome Res 10:4005-4017
12. Zhao L, Liu Y, Sun X, Peng K, Ding Y (2011) Serum proteome analysis for pro fi ling protein markers associated with lymph node metastasis in colorectal carcinoma. J Comp Pathol 144:187-194
13. Liao Q, Zhao L, Chen X, Deng Y, Ding Y (2008) Serum proteome analysis for pro fi ling protein markers associated with carcinogenesis and lymph node metastasis in nasopharyngeal carcinoma. Clin Exp Metastasis 25:465-476
14. Hamrita B, Chahed K, Trimeche M et al (2009) Proteomics-based identi fi cation of alpha1-antitrypsin and haptoglobin precursors as novel serum markers in in fi ltrating ductal breast carcinomas. Clin Chim Acta 404: 111-118
15. Kaur P, Reis MD, Couchman GR, Forjuoh SN, Greene JF, Asea A (2010) SERPINE 1 links obesity and diabetes: a pilot study. J Proteomics Bioinform 3:191-199
16. Fratantoni SA, Piersma SR, Jimenez CR (2010) Comparison of the performance of two af fi nity depletion spin fi lters for quantitative proteomics of CSF: evaluation of sensitivity and reproducibility of CSF analysis using GeLC-MS/MS and spectral counting. Proteomics Clin Appl 4:613-617
17. Siegmund R, Kiehntopf M, Deufel T (2009) Evaluation of two different albumin depletion strategies for improved analysis of human CSF by SELDI-TOF-MS. Clin Biochem 42: 1136-1143
18. Zuberovic A, Hanrieder J, Hellman U, Bergquist J, Wetterhall M (2008) Proteome pro fi ling of human cerebrospinal fl uid: exploring the potential of capillary electrophoresis with surface modi fi ed capillaries for analysis of complex biological samples. Eur J Mass Spectrom 14:249-260
19. Thouvenot E, Urbach S, Dantec C et al (2008) Enhanced detection of CNS cell secretome in plasma protein-depleted cerebrospinal fl uid. J Proteome Res 7:4409-4421
20. Sigdel TK, Lau K, Schilling J, Sarwal M (2008) Optimizing protein recovery for urinary proteomics, a tool to monitor renal transplantation. Clin Transplant 22:617-623
21. Zolotarjova N, Martosella J, Nicol G, Bailey J, Boyes BE, Barrett WC (2005) Differences among techniques for high-abundant protein depletion. Proteomics 5:3304-3313
22. Koutroukides TA, Guest PC, Leweke FM et al (2011) Characterization of the human serum depletome by label-free shotgun proteomics. J Sep Sci 34:1621-1626
23. Fania C, Vasso M, Torretta E et al (2011) Setup for human sera MALDI pro fi ling: the case of rhEPO treatment. Electrophoresis 32:1715-1727
24. Martosella J, Zolotarjova N, Liu H, Nicol G, Boyes BE (2005) Reversed-phase high-performance liquid chromatographic prefractionation of immunodepleted human serum proteins to enhance mass spectrometry identi fi cation of lower-abundant proteins. J Proteome Res 4:1522-1537
25. Björhall K, Miliotis T, Davidsson P (2005) Comparison of different depletion strategies for improved resolution in proteomic analysis of human serum samples. Proteomics 5:307-317